EFPIA - NEWSLETTER

EFPIA Newsletter 06 May 2021

EFPIA statement on IP waiver for COVID-19 vaccines

While we wholeheartedly agree with the goal of protecting citizens around the world through vaccines, waiving patents will make winning the fight against the coronavirus even harder.

Speaking about the US administration’s decision to support a proposal to waive patents on COVID-19 vaccines, EFPIA Director General Nathalie Moll said. “This short-sighted and ineffectual decision by the Biden administration puts the hard-won progress in fighting this terrible disease in jeopardy. While we wholeheartedly agree with the goal of protecting citizens around the world through vaccines, waiving patents will make winning the fight against the coronavirus even harder.”

News

06 May 2021 EFPIA response to the publication of the updated EU Industrial Strategy

The EU pharmaceutical strategy should be aligned with the industrial strategy and focused on ensuring that Europe remains...

06 May 2021 EFPIA statement on the EU Strategy on COVID Therapeutics

There are currently nearly 3000 clinical trials exploring therapeutics for treating COVID patients and around 61 therapeutic...

30 April 2021 Coming together to create faster, more equitable access to medicines across Europe

Addressing Healthcare Challenges: Principles on the Transparency of Evidence from Novel Pricing and Payment Models

19 Conversations | The EFPIA Podcast Series

05 May 2021 Podcast: How can we improve healthcare access for marginalised communities?

Welcome to 19 conversations

30 April 2021 Podcast: What value do Public Private Partnerships bring for society?

Welcome to 19 conversations

EFPIA 2021 Connecting Healthcare Awards

Meet the project winners of the Connecting Healthcare Innovation Award: The Dreamcatcher, in our video interview:

Events

25 MAY 2021

Unlocking the potential of the European Health Data Space to improve diabetes management... Virtual event

The first in a two-part series co-hosted by the EFPIA Diabetes Platform and the European Diabetes Forum (EUDF)

Learn more →

10 JUN 2021

Unlocking the power of health data: the promise of the European Health Data Space... Virtual event

A virtual event hosted by EFPIA and MedTech Europe

Learn more →

Why are you #TeamVaccines?

Watch the latest #TeamVaccines videos on the Vaccines Europe website here and find out why we are all on #TeamVaccines:

What we are reading

Industry weary of waiving vaccine patents 06 May 2021 (DW.com)

Using data to raise awareness and initiate action to improve outcomes for people with diabetes... 06 May 2021 (EUDF)

Commission aims to roll out COVID-19 travel certificates by June 03 May 2021 (Euractiv)

Waiving IP rules will not deliver more Covid vaccines 25 May 2021 (Financial Times)

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
Communications@efpia.eu

▶